Page 95 - Coronary hemodynamics in acute myocardial infarction - Matthijs Bax

Coronary microvascular function and long-term mortality
31. Furber AP, Prunier F, Nguyen HC, Boulet S, Delépine S, Geslin P. Coronary blood flow assessment after successful angioplasty for acute myocardial infarction predicts the risk of long-term cardiac events. Circulation. 2004;110:3527–3533.
32. Lew WY, Chen ZY, Guth B, Covell JW. Mechanisms of augmented segment shortening in nonischemic areas during acute ischemia of the canine left ventricle. Circ Res. 1985;56:351–358.
33. Lew WY. Influence of ischemic zone size on nonischemic area function in the canine left ventricle. Am J Physiol. 1987;252(5 pt 2):H990–H997.
34. Westerhof N, Boer C, Lamberts RR, Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev. 2006;86:1263–1308.
35. Masuyama T, Uematsu M, Doi Y, Yamamoto K, Mano T, Naito J, Kondo H, Nagano R, Hori M, Kamada T. Abnormal coronary flow dynamics at rest and during tachycardia associated with impaired left ventricular relaxation in humans: implication for tachycardia-induced myocardial ischemia. J Am Coll Cardiol. 1994;24:1625–1632.
36. Watanabe J, Levine MJ, Bellotto F, Johnson RG, Grossman W. Left ventricular diastolic chamber stiffness and intramyocardial coronary capacitance in isolated dog hearts. Circulation. 1993;88:2929–2940.
37. Van Herck PL, Carlier SG, Claeys MJ, Haine SE, Gorissen P, Miljoen H, Bosmans JM, Vrints CJ. Coronary
microvascular dysfunction after myocardial infarction: increased coronary zero flow pressure both
in the infarcted and in the remote myocardium is mainly related to left ventricular filling pressure.
Heart. 2007;93:1231–1237. 5
38. Guzzetti S, Spyrou N, Rosen SD, Mezzetti S, Martinoli E, Foale RA, Camici PG. Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction. Basic Res Cardiol. 2002;97:97–104.
39. Heusch G, Baumgart D, Camici P, Chilian W, Gregorini L, Hess O, Indolfi C, Rimoldi O. alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation. 2000;101:689–694.
40. Schäfer U, Kurz T, Jain D, Hartmann F, Dendorfer A, Tölg R, Raasch W, Dominiak P, Katus H, Richardt G. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? Basic Res Cardiol. 2002;97:399–408.
41. Feigl EO. The paradox of adrenergic coronary vasoconstriction. Circulation. 1987;76:737–745.
42. Feigl EO. Control of myocardial oxygen tension by sympathetic coronary vasoconstriction in the dog. Circ Res. 1975;37:88–95.
43. Mohrman DE, Feigl EO. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res. 1978;42:79–86.
44. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, Johnson BD, Sopko G, Bairey Merz CN. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55:2825–2832.
45. van Liebergen RA, Piek JJ, Koch KT, de Winter RJ, Lie KI. Immediate and long-term effect of balloon angioplasty or stent implantation on the absolute and relative coronary blood flow velocity reserve. Circulation. 1998;98:2133–2140.
46. De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR. Intracoronary and intravenous adenosine 5’-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107:1877–1883.
93